Novan ROA 2015-2018 | NOVN

Current and historical return on assets (ROA) values for Novan (NOVN) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Novan ROA for the three months ending September 30, 2018 was -82.50%.
Novan ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-09-30 $-0.03B $0.03B -85.29%
2018-06-30 $-0.03B $0.04B -85.93%
2018-03-31 $-0.03B $0.05B -93.23%
2017-12-31 $-0.04B $0.02B -108.82%
2017-09-30 $-0.04B $0.03B -98.20%
2017-06-30 $-0.05B $0.04B -98.08%
2017-03-31 $-0.06B $0.05B -138.01%
2016-12-31 $-0.06B $0.05B -193.44%
2016-09-30 $-0.05B $0.07B -262.86%
2016-06-30 $-0.04B $0.00B inf%
2016-03-31 $-0.02B $0.00B -680.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.036B $0.002B
Novan, Inc. is a pharmaceutical company. It engaged in the development and commercialization of therapies using its nitric oxide platform for dermatology. The Company's product candidates primarily include SB204, SB206, SB208 and SB414 which are in pre-clinical trial stage. It develops product through Nitricil technology(TM). Novan, Inc. is based in Durham, United States.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $53.940B 11.50
Zoetis (ZTS) United States $43.692B 29.91
Grifols (GRFS) Spain $13.035B 15.91
Jazz Pharmaceuticals (JAZZ) Ireland $8.572B 12.30
Ionis Pharmaceuticals (IONS) United States $7.356B 0.00
Tilray (TLRY) United States $7.036B 0.00
Neurocrine Biosciences (NBIX) United States $6.621B 1460.20
Nektar Therapeutics (NKTR) United States $6.577B 9.43
Catalent (CTLT) United States $5.241B 21.98
Impax Laboratories (AMRX) United States $4.876B 25.92
United Therapeutics (UTHR) United States $4.801B 7.85
Sage Therapeutics (SAGE) United States $4.718B 0.00
Loxo Oncology (LOXO) United States $4.286B 0.00
TESARO (TSRO) United States $4.100B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.569B 13.22
FibroGen (FGEN) United States $3.346B 0.00
USANA Health Sciences (USNA) United States $2.947B 25.09
Endo (ENDP) Ireland $2.499B 3.83
Xencor (XNCR) United States $2.132B 0.00
Heron Therapeutics (HRTX) United States $2.033B 0.00
Corcept Therapeutics (CORT) United States $1.985B 29.14
Endocyte (ECYT) United States $1.959B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.883B 254.44
Aerie Pharmaceuticals (AERI) United States $1.773B 0.00
Zogenix (ZGNX) United States $1.757B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.736B 0.00
PTC Therapeutics (PTCT) United States $1.703B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.667B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.501B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.413B 19.88
Esperion Therapeutics (ESPR) United States $1.366B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.365B 0.00
Tricida (TCDA) United States $1.307B 0.00
Portola Pharmaceuticals (PTLA) United States $1.270B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.238B 0.00
TherapeuticsMD (TXMD) United States $0.966B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.942B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.813B 0.00
ImmunoGen (IMGN) United States $0.804B 0.00
Radius Health (RDUS) United States $0.727B 0.00
Forty Seven (FTSV) United States $0.697B 0.00
Collegium Pharmaceutical (COLL) United States $0.622B 0.00
Karyopharm Therapeutics (KPTI) United States $0.596B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.519B 0.00
Flexion Therapeutics (FLXN) United States $0.518B 0.00
Siga Technologies (SIGA) United States $0.517B 0.00
ChemoCentryx (CCXI) United States $0.512B 40.56
Akebia Therapeutics (AKBA) United States $0.496B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.460B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.437B 25.75
GlycoMimetics (GLYC) United States $0.436B 0.00
Dermira (DERM) United States $0.435B 0.00
Tyme Technologies (TYME) United States $0.431B 0.00
Xeris Pharmaceuticals (XERS) United States $0.421B 0.00
Dova Pharmaceuticals (DOVA) United States $0.420B 0.00
CASI Pharmaceuticals (CASI) United States $0.407B 0.00
Odonate Therapeutics (ODT) United States $0.406B 0.00
KalVista Pharmaceuticals (KALV) United States $0.402B 0.00
Translate Bio (TBIO) United States $0.394B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.379B 0.00
ArQule (ARQL) United States $0.368B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.352B 0.00
Majesco Entertainment (PTE) United States $0.347B 0.00
OptiNose (OPTN) United States $0.320B 0.00
Concert Pharmaceuticals (CNCE) United States $0.314B 0.00
Aclaris Therapeutics (ACRS) United States $0.313B 0.00
Tapimmune (MRKR) United States $0.308B 0.00
Minerva Neurosciences (NERV) United States $0.304B 0.00
Aratana Therapeutics (PETX) United States $0.301B 0.00
Depomed (ASRT) United States $0.269B 10.00
Verrica Pharmaceuticals (VRCA) United States $0.263B 0.00
Mast Therapeutics (SVRA) United States $0.257B 0.00
IMV INC (IMV) Canada $0.254B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.253B 0.00
Aldeyra Therapeutics (ALDX) United States $0.249B 0.00
Affimed (AFMD) Germany $0.233B 0.00
Ocular Therapeutix (OCUL) United States $0.232B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.217B 0.00
Galectin Therapeutics (GALT) United States $0.207B 0.00
Lannett Co Inc (LCI) United States $0.199B 1.73
Aquestive Therapeutics (AQST) United States $0.199B 0.00
Zafgen (ZFGN) United States $0.197B 0.00
TAIWAN LIPOSOME (TLC) Taiwan $0.188B 0.00
Opexa Therapeutics (ACER) United States $0.184B 0.00
Calithera Biosciences (CALA) United States $0.181B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.178B 0.00
Molecular Templates (MTEM) United States $0.175B 0.00
MEI Pharma (MEIP) United States $0.174B 0.00
Nature's Sunshine Products (NATR) United States $0.169B 0.00
ContraFect (CFRX) United States $0.163B 0.00
Recro Pharma (REPH) United States $0.163B 0.00
Neon Therapeutics (NTGN) United States $0.156B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.156B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.150B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.143B 0.00
Redhill Biopharma (RDHL) Israel $0.142B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.138B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.137B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.137B 0.00
Ardelyx (ARDX) United States $0.136B 0.00
Cardiome Pharma (CORV) Canada $0.133B 0.00
MediWound (MDWD) Israel $0.132B 0.00
ElectroCore (ECOR) United States $0.131B 0.00
Jounce Therapeutics (JNCE) United States $0.121B 0.00
Adherex Technologies (FENC) United States $0.118B 0.00
DURECT (DRRX) United States $0.118B 0.00
Rafael Holdings (RFL) United States $0.114B 0.00
Champions Oncology (CSBR) United States $0.109B 0.00
ProNAi Therapeutics (SRRA) Canada $0.109B 0.00
Iterum Therapeutics (ITRM) Ireland $0.105B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.100B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.093B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.088B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.085B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.082B 0.00
Immune Design (IMDZ) United States $0.082B 0.00
Achaogen (AKAO) United States $0.079B 0.00
CTI BioPharma (CTIC) United States $0.079B 0.00
Natural Alternatives (NAII) United States $0.074B 7.27
Melinta Therapeutics (MLNT) United States $0.072B 0.00
Otonomy (OTIC) United States $0.072B 0.00
Infinity Pharmaceuticals (INFI) United States $0.068B 0.00
BioLineRx (BLRX) Israel $0.068B 0.00
Nivalis Therapeutics (ALPN) United States $0.067B 0.00
KemPharm (KMPH) United States $0.066B 0.00
Neos Therapeutics (NEOS) United States $0.059B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.059B 36.64
Avenue Therapeutics (ATXI) United States $0.054B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.050B 0.00
Genocea Biosciences (GNCA) United States $0.049B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.047B 0.00
Forward Pharma (FWP) Denmark $0.046B 0.00
Mannatechorporated (MTEX) United States $0.045B 0.00
Capnia (SLNO) United States $0.038B 0.00
ProPhase Labs (PRPH) United States $0.037B 4.12
XTL Biopharmaceuticals (XTLB) Israel $0.036B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.034B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.032B 0.00
Heat Biologics (HTBX) United States $0.030B 0.00
Lipocine (LPCN) United States $0.030B 0.00
IsoRay (ISR) United States $0.028B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.027B 0.00
Trillium Therapeutics (TRIL) Canada $0.026B 0.00
Can-Fite Biopharma (CANF) Israel $0.025B 0.00
SCYNEXIS (SCYX) United States $0.025B 0.00
Xenetic Biosciences (XBIO) United States $0.024B 0.00
Biomerica (BMRA) United States $0.024B 0.00
NanoViricides (NNVC) United States $0.022B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.022B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.022B 0.00
PharmAthene (ALT) United States $0.021B 0.00
HANCOCK JAFFE (HJLI) United States $0.021B 0.00
Cyanotech (CYAN) United States $0.021B 0.00
Jaguar Animal Health (JAGX) United States $0.021B 0.00
Aviragen Therapeutics (VXRT) United States $0.019B 0.00
Pain Therapeutics (PTIE) United States $0.019B 0.00
Citius Pharmaceuticals (CTXR) United States $0.019B 0.00
Onconova Therapeutics (ONTX) United States $0.018B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.017B 6.10
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.016B 0.00
ESSA Pharma (EPIX) Canada $0.016B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.015B 0.00
Shineco (TYHT) China $0.013B 1.43
Regulus Therapeutics (RGLS) United States $0.012B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.010B 0.00
Skyline Medical (AIPT) United States $0.010B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.010B 0.00
Apricus Biosciences (APRI) United States $0.009B 0.00
Aradigm (ARDM) United States $0.008B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.008B 0.00
RXi Pharmaceuticals (PHIO) United States $0.006B 0.00
Midatech Pharma (MTP) United Kingdom $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.004B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.004B 0.00
Bio Blast Pharma (ORPN) Israel $0.004B 0.00
Bio-Path Holdings (BPTH) United States $0.004B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.003B 0.00
Intellipharmaceutics (IPCI) Canada $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
AGEX THERAPEUTC (AGE) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00